Literature DB >> 23524258

Regulation of miR-155 biogenesis in cystic fibrosis lung epithelial cells: antagonistic role of two mRNA-destabilizing proteins, KSRP and TTP.

Sharmistha Bhattacharyya1, Parameet Kumar, Motohiro Tsuchiya, Anirban Bhattacharyya, Roopa Biswas.   

Abstract

Cystic fibrosis (CF) is characterized by a massive pro-inflammatory phenotype in the lung arising from profound expression of inflammatory genes, including interleukin-8 (IL-8). We have previously reported that IL-8 mRNA is stabilized in CF lung epithelial cells, resulting in concomitant hyper-expression of IL-8 protein through elevated expression of miR-155. We therefore investigated what factors promote the enhanced aberrant expression of miR-155 in CF. Here we report for the first time, the role of mRNA-destabilizing inflammatory RNA-binding proteins, KSRP and TTP, in the regulation of miR-155 biogenesis in CF lung epithelial cells. We find that KSRP and TTP have an antagonistic role in miR-155 biogenesis. While KSRP promotes enhanced processing of miR-155 precursors to mature miR-155, over-expression of TTP in the CF lung epithelial cells suppresses expression of miR-155. We find that TTP induces the expression of miR-1, which appears to be a regulator of miR-155 biogenesis in CF lung epithelial cells. These data provide novel insights into the mechanisms that induce hyper-inflammatory phenotype of CF, and are potential candidates for anti-inflammatory therapeutics for CF. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23524258     DOI: 10.1016/j.bbrc.2013.03.025

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Regulation of context-specific gene expression by posttranscriptional switches.

Authors:  Gopinath M Sundaram; Prabha Sampath
Journal:  Transcription       Date:  2013 Sep-Dec

Review 2.  MicroRNA-155: A Master Regulator of Inflammation.

Authors:  Guruswamy Mahesh; Roopa Biswas
Journal:  J Interferon Cytokine Res       Date:  2019-03-20       Impact factor: 2.607

3.  miR-16 rescues F508del-CFTR function in native cystic fibrosis epithelial cells.

Authors:  P Kumar; S Bhattacharyya; K W Peters; M L Glover; A Sen; R T Cox; S Kundu; H Caohuy; R A Frizzell; H B Pollard; R Biswas
Journal:  Gene Ther       Date:  2015-07-02       Impact factor: 5.250

Review 4.  Role of KSRP in control of type I interferon and cytokine expression.

Authors:  Peter H King; Ching-Yi Chen
Journal:  J Interferon Cytokine Res       Date:  2014-04       Impact factor: 2.607

Review 5.  Novel insights into miRNA in lung and heart inflammatory diseases.

Authors:  Amit Kishore; Jana Borucka; Jana Petrkova; Martin Petrek
Journal:  Mediators Inflamm       Date:  2014-05-27       Impact factor: 4.711

Review 6.  Environmental exposures in utero and microRNA.

Authors:  Maya Kappil; Jia Chen
Journal:  Curr Opin Pediatr       Date:  2014-04       Impact factor: 2.856

Review 7.  MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis.

Authors:  Stefano Alivernini; Elisa Gremese; Charles McSharry; Barbara Tolusso; Gianfranco Ferraccioli; Iain B McInnes; Mariola Kurowska-Stolarska
Journal:  Front Immunol       Date:  2018-01-05       Impact factor: 7.561

8.  Tristetraprolin expression and microRNA-mediated regulation during simian immunodeficiency virus infection of the central nervous system.

Authors:  Jonathan Liu; Jeanne M Sisk; Lucio Gama; Janice E Clements; Kenneth W Witwer
Journal:  Mol Brain       Date:  2013-09-02       Impact factor: 4.041

9.  Targeting miR-155 to Treat Experimental Scleroderma.

Authors:  Qingran Yan; Jie Chen; Wei Li; Chunde Bao; Qiong Fu
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

10.  CFTR promotes malignant glioma development via up-regulation of Akt/Bcl2-mediated anti-apoptosis pathway.

Authors:  Mingyue Zhao; Jieting Zhang; Wenqing Huang; Jianda Dong; Jinghui Guo; Kin Pong U; ZhiHui Weng; Si Liu; Hsiao Chang Chan; Hua Feng; Xiaohua Jiang
Journal:  J Cell Mol Med       Date:  2020-05-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.